Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
23/03/2026 12:35
March 23 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A: NOVABAY PHARMACEUTICALS ANNOUNCES NAME CHANGE TO STABLECOIN DEVELOPMENT CORPORATION, REPORTS INITIAL STAKING REWARDS, AND PROVIDES SKY TOKEN HOLDINGS UPDATE Source text: ID:nGNXBK1Fl Further company coverage: NBY.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing